Motion Relief Logo
Motion Relief
BlogLearnBreathePricing
LoginGet started
Emerging triggers · Complete guide

The future of motion sickness

Autonomous vehicles, space tourism, mixed reality, and digital therapeutics are reshaping the motion sickness landscape. This guide maps every emerging trigger, explains why the problem is about to get much bigger, and shows what the brain training solution looks like across every context — current and future.

Take the free assessmentStart reading

20–33%

AV passengers projected to be affected
Autonomous vehicles are about to create motion sickness at consumer scale — the value proposition depends on solving it.

60–80%

Of first-time space travelers affected
Space Adaptation Syndrome strikes most civilians on orbital missions. Commercial space companies are not solving this for you.

51–58%

Susceptibility reduced with brain training
The same 14-day program that works for cars and boats builds resilience for every emerging trigger — because the brain is the common variable.

All triggers

One trained brain handles them all
Autonomous vehicles, VR, space travel — every new trigger works through the same sensory conflict mechanism. Train once, protect against all.
The premise

Why motion sickness is about to become a much bigger problem

For most of history, motion sickness came from a few familiar sources. In the last decade, that list has started expanding rapidly — and the pace is accelerating.

The problem
Every new technology creates new sensory conflicts

Motion sickness happens when your eyes and inner ear send conflicting signals to your brain. Autonomous vehicles remove the driver's predictive advantage. VR creates intense visual-vestibular mismatch. Space tourism removes gravity itself. Each new technology creates a new sensory conflict your brain wasn't designed to handle — at a scale no previous generation encountered.

The scale
Mass-scale new triggers are arriving simultaneously

AVs could affect 20–33% of the US population during daily commutes. VR headset ownership already exceeds 30 million users globally and is growing. Space tourism is opening to paying customers. Each of these is a new motion sickness problem at consumer scale — arriving within the same decade.

The solution
The brain is the common variable across every trigger

Every emerging trigger — AV rides, VR sessions, orbital flights — works through the same sensory conflict mechanism. The brain's ability to rapidly integrate mismatched sensory inputs determines susceptibility across all of them. Training that ability now produces resilience that transfers to every trigger you'll encounter, including the ones that don't exist yet.

Section 1

Autonomous vehicles: the next mass-scale motion sickness problem

The entire value proposition of autonomous vehicles depends on passengers doing something other than watching the road. Work, read, watch content, have a conversation. The problem: every one of those activities is a motion sickness trigger. Research projects that 20–33% of passengers could experience meaningful discomfort in AVs specifically because of this shift in behavior.

Early Waymo, Cruise, and Tesla FSD users are already reporting it. Automakers are working on the vehicle side — motion-synchronized lighting, AI driving profiles, haptic anticipation cues. None of these solutions change the passenger's underlying susceptibility. The people who will have the best AV experiences are the ones whose brains are trained for sensory conflict — starting now, before the AV transition is complete.

The core problem
When you're a passenger rather than a driver, you lose the predictive advantage that protects drivers. Your brain receives motion as unpredictable input with no anticipatory context.
Activity hierarchy
Reading and screen work are worst. Audio-only content produces the least conflict. The AV promise (productive ride time) conflicts with the comfort requirement (no screen use).
Industry response
Interior lighting, AI driving profiles, haptic cues, and cabin redesigns partially reduce the problem. None change the underlying human susceptibility.
Training solution
Visuospatial training improves sensory conflict processing across all trigger types, including AV rides — building resilience that transfers across every platform you'll ride.
Self-Driving Car Motion Sickness: The Problem No One Is Talking About
Science
Self-Driving Car Motion Sickness: The Problem No One Is Talking About
Why autonomous vehicles cause more motion sickness than human-driven cars, what the research shows, what automakers are doing, and how to prepare your brain now.
Read the full article
Section 2

Space tourism: a premium market with a preparation gap

Commercial space tourism is real. Virgin Galactic, Blue Origin, SpaceX, and Axiom Space have collectively flown hundreds of paying civilians above Earth. By 2030, analysts project a $3–5 billion market. The problem almost no one discusses: Space Adaptation Syndrome affects 60–80% of first-time orbital travelers, and commercial space companies are focused on safety training, not vestibular preparation.

For suborbital flights (Virgin Galactic, Blue Origin), SAS is typically mild and short-lived — the weightlessness window is only 3–6 minutes. For orbital flights (SpaceX Crew Dragon, Axiom Space), passengers should expect 24–48 hours of adaptation symptoms. Pre-flight vestibular training cannot replicate microgravity, but it raises your baseline processing capacity so your brain adapts faster once you're in space.

Suborbital flights
3–6 minutes of weightlessness. Most passengers experience disorientation and some nausea. Short duration limits severity.
Orbital flights
3+ days in microgravity. SAS highly likely. Pre-flight training shortens adaptation window from 48 hours to 12–24 hours for many passengers.
The preparation gap
Commercial space companies provide safety training, not vestibular preparation. The responsibility for pre-flight conditioning falls on the passenger.
Section 3

VR and AR: the current consumer frontier

VR motion sickness is the current leading edge of this problem at consumer scale. Cybersickness affects 25–40% of VR users and is the most significant barrier to VR adoption. Unlike AV motion sickness (mild, sustained sensory conflict) or space sickness (no gravity reference), VR sickness is intense and short-duration — the visual-vestibular mismatch is extreme because the visual system sees full 3D motion while the body doesn't move.

AR and spatial computing (Apple Vision Pro, Meta Ray-Ban smart glasses) extend the category by overlaying digital elements on the real world — creating subtler but persistent forms of sensory conflict in everyday environments. As mixed reality moves from early adoption to mainstream, the affected population will grow substantially.

VR and AR have dedicated deep coverage

VR motion sickness is the most-researched emerging trigger and warrants its own complete guide. For everything from headset selection to cybersickness treatment to long-term VR tolerance building, see:

Complete Guide to VR Motion Sickness
Section 4

Digital treatment: catching up with emerging triggers

As new motion sickness triggers emerge at consumer scale, the treatment landscape is shifting in parallel. Vestibular rehabilitation has moved from specialist in-clinic care to app-delivered programs accessible to anyone. AI-personalized protocols, biometric-adaptive training, and VR-native vestibular exercises are either here or arriving imminently.

Motion sickness is particularly well-suited to digital treatment: the intervention is exercise-based, requires no equipment, and is highly adherence-sensitive — the more consistently you do the program, the better it works. Digital delivery solves the access and adherence problems that limited in-clinic vestibular therapy.

Consumer apps
Structured brain training programs delivering vestibular and visuospatial exercises. The most accessible entry point for standard motion sickness.
Clinical digital VRT
App-based delivery of clinical vestibular rehabilitation protocols. Equivalent outcomes to in-clinic care, significantly better access. FDA prescription digital therapeutic pathway developing.
Section 5

What stays constant: the training principle

Through every new technology and trigger — autonomous vehicles, space tourism, mixed reality, whatever comes next — the underlying biology remains unchanged. Motion sickness is a sensory integration problem. The brain receives conflicting signals from the eyes, the inner ear, and the body, and responds with nausea. The degree of that response depends on how efficiently the brain resolves the conflict.

University of Warwick · 2021
51–58%

reduction in motion sickness susceptibility

14 days of visuospatial brain training at ~15 minutes per day. Results transferred across car, boat, and visual motion stimuli — the same mechanism that drives every current and future trigger.

Investing in brain training today is an investment in every autonomous vehicle ride, every VR session, and every future motion context you will encounter. The improvement is lasting and transferable — it doesn't expire when the next technology arrives.

For the complete brain training guide, see our Complete Guide to Training Your Brain to Prevent Motion Sickness. The research suggests this improvement is lasting and transferable across trigger types.

Section 6

Where treatment is heading

A brief look at the major directions in motion sickness treatment innovation over the next decade.

1
Pharmaceutical
Selective compounds without sedation
Next-generation receptor-targeted compounds that address the nausea pathway without the broad neurotransmitter blockade that causes drowsiness. Still require ongoing use — they address symptoms, not susceptibility.
2
Digital therapeutics
AI-personalized, insurance-covered
Prescription digital therapeutics pathway maturing. AI models trained on population-level outcomes personalizing protocols to individual susceptibility profiles. Insurance coverage expanding.
3
Neuromodulation
GVS and non-invasive brain stimulation
Galvanic vestibular stimulation from research to clinical and consumer use. Transcranial magnetic stimulation for vestibular processing enhancement. Closed-loop neurofeedback systems.
4
Precision medicine
Genetic profiling guides treatment
35+ genetic variants associated with susceptibility. Precision medicine approach: your genetic profile informs which intervention will be most effective, rather than trial-and-error.
The Future of Motion Sickness Treatment
Science
The Future of Motion Sickness Treatment
Pharmaceutical pipeline, AI-personalized digital therapeutics, neuromodulation, precision medicine, and what treatment will look like by 2030.
Read the full article
Section 7

The emerging technology landscape

Beyond the consumer products already established — wristbands, medication, motion glasses — a new generation of motion sickness technology is emerging. Galvanic vestibular stimulation wearables deliver precise electrical signals to the vestibular nerve. Smart glasses dynamically reduce peripheral visual input during high-conflict moments. AI-driven biometric monitoring detects early-warning nausea signals before symptoms are consciously felt.

The integration trajectory: wearables, apps, and environmental systems combining into seamless ambient intervention — the vehicle, the glasses, and the app coordinating to reduce sensory conflict continuously without requiring conscious attention. Each of these approaches addresses triggers or symptoms. None of them changes your underlying susceptibility. Brain training does.

For the complete technology landscape, including the research frontier and where each category is heading, see our Motion Sickness Technology guide.

Build resilience for whatever's coming

The free assessment takes under 3 minutes. It identifies your current motion sickness severity and creates the training path most likely to reduce your susceptibility across every current and future trigger.

Take the free assessment